ATAI
AtaiBeckleyBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ATAI vs peer average
71/100
ATAI vs. peer average (B vs. C)
Grade spread
B 2 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
EYPT is the first available peer comparator.
EyePoint is another small-cap biotech where upcoming trial readouts and financing capacity shape valuation; it is not an indication match, but it is a more useful risk/market-cap comparator than broad pharma names.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ATAI
AtaiBeckley
EYPT
EyePoint
Grade
B
C
Momentum
67
27
Value
41
41
Sentiment
62
78
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs EYPT
ATAI / EYPT
Grade Position
Above peers
ATAI vs. peer average (B vs. C)
71/100
Momentum
67
ATAIValue
41
ATAISentiment
62
EYPTRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ATAI
EYPT is the first peer returned for this comparison set.